Quick Heal

Pune, India Founded: 1995 • Age: 31 yrs Listed
Endpoint security is delivered via cloud-based antivirus software.

About Quick Heal

Quick Heal is a publicly listed company based in Pune (India) founded in 1995 by Kailash Katkar and Sanjay Katkar. Endpoint security is delivered via cloud-based antivirus software. The company has 977 employees. Quick Heal has completed 1 acquisition, including Junco Technologies. Quick Heal was last valued at $124.91 million in August 2010. Its chief executive, as recorded, is Kailash Katkar. Its website quickheal.co.in draws about 502 thousand monthly visits. Its Indian entity Quick Heal Technologies Limited reported revenue of β‚Ή284 Cr. Its focus areas include Enterprise Infrastructure, Cybersecurity, Endpoint Security and Anti Malware.

Company details

Quick Heal was founded in 1995 in Pune, India, within the cybersecurity sector. A cloud-based platform is operated to provide endpoint security through antivirus solutions for PCs, laptops, Macs, and Windows devices. Protection from cyber attacks and threats is ensured, supporting device performance and user security across operations.

  • Headquarters Pune, India
  • Employees 977
  • Founders Kailash Katkar, Sanjay Katkar
  • Stage Public
  • Sectors
    Technology
  • Website category Computers Electronics and Technology · Search Engines
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website quickheal.co.in
  • Social LinkedIn X Facebook
  • Legal Name Quick Heal Technologies Ltd.
Key Metrics
  • Market Cap
    ₹827 Cr

    QUICKHEAL · NSE

  • Share Price
    ₹152.44

    +0.67% today

  • Revenue
    ₹261 Cr

    FY 2025-26 · -6.6% YoY

  • EBITDA
    −₹29.37 Cr

    Margin -11.2%

  • Net Profit
    −₹16.76 Cr

    FY 2025-26 · -709.5% YoY

  • ROE
    -3.8%

    ROCE -6.0%

  • Latest Funding Round
    $8.27M (USD), Unspecified

    Aug 2010

  • Investors
  • Employee Count
    977
  • Investments & Acquisitions

Apps and channels of Quick Heal

Quick Heal publishes 1 mobile app with over 10M+ downloads.

Antivirus and Mobile Security
Google Play Tools Everyone Free 10M+ downloads
Developer: Quick Heal Technologies
View on Google Play

Funding Insights of Quick Heal

  • Total Rounds 1
  • Last Round Unspecified β€” $8.27M
  • First Round $8.27M

    (Aug 2010)

  • Investors Count 2

All 1 funding rounds of Quick Heal with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Aug 2010$8.27MUnspecified$124.91MPeak XV Partners
Valuation history
DateValuationStage
Aug 2010$124.91Mβ€’β€’β€’β€’β€’β€’β€’β€’

Last known valuation $124.91M (Aug 2010). 2 investors in total: 2 institutional.

Investors in Quick Heal

Quick Heal has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include Peak XV Partners and RippleWave.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Venture capital firm investing in startups and providing support programs.
2000peakxv.comBengaluru, India
Email and mail server services.
2008ripplewave.netMumbai, India
Premium access

Investor details for Quick Heal

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Quick Heal Technologies Limited (Quick Heal)

Quick Heal Technologies Limited is the primary company behind Quick Heal. The boards of the 2 registered companies of Quick Heal currently have 7 directors; the longest-serving is Kailash Sahebrao Katkar, appointed in 1995. 35 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Kailash Sahebrao Katkar
DIN 00397191
Managing Director17 Aug 199531 yrs 2 moQuick Heal Technologies Limited
Sanjay Katkar Sahebrao
DIN 00397277
Managing Director17 Aug 199531 yrs 2 moQuick Heal Technologies Limited
Amitabha Mukhopadhyay
DIN 01806781
Director10 Jun 20197 yrs 5 moQuick Heal Technologies Limited
Kamal Kumar Agarwal
DIN 02831435
Director26 Jul 20242 yrs 3 moQuick Heal Technologies Limited
Pooja Parag Rathi
DIN 07393897
Designated Partner08 Jan 20251 yr 10 moGagan Bharari Enterprises Llp
Amod Santosh Tirmanwar
DIN 10898242
Designated Partner08 Jan 20251 yr 10 moGagan Bharari Enterprises Llp
Amita Shantanu Mirajkar
DIN 06945253
Director07 Aug 20251 yr 3 moQuick Heal Technologies Limited

People of Quick Heal

142 people are tracked at Quick Heal (23 in leadership, 119 in team); the tracked headcount is 977.

NameRoleGroup
Co-Founder & CEOLeadership
Co-Founder & CTOLeadership
Sourav Kar
Program Manager - Strategy - Ceo’s OfficeLeadership
Vishal Salvi
CEOLeadership
Sudhanshu Tripathi
Chief Marketing Officer & Head ESGLeadership
Sonal Raj
Marketing Director - Global Consumer BusinessLeadership
Ashish Pradhan
CTOLeadership
Swapna Sangari
VP, Human ResourcesLeadership
Dr. Lalit Mohan Sanagavarapu
Chief Product OfficerLeadership
Shahid M.
Director EngineeringLeadership
Swapna Sangarri
Vice President Human ResourcesLeadership
Souvik D.
Director Of Engineering - Enterprise & Retail Products (anti-virus, Anti-fraud, Emm)Leadership
Rehan A A
Western India HeadLeadership
Deepak Mishra
Head, Retail SalesLeadership
Jaswinder Singh
Director Of EngineeringLeadership
Ankit Maheshwari
Chief Financial OfficerLeadership
Sneha Katkar
Head Of Product StrategyLeadership
Venu Gopal Dubey
Head Sales Business DevelopmentLeadership
Gitesh Patle
Director FinanceLeadership
Navaneeth Krishnan Nadar
Head PresalesLeadership

122 more people are available in the full profile.

Premium access

Complete people profiles for Quick Heal

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of Quick Heal

Quick Heal is a publicly listed company on the NSE with ticker symbol QUICKHEAL in India, operating in the Technology services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date18 Feb 2016
  • Listed onNSE: QUICKHEAL · BSE: 539678
  • Listed entityQuick Heal Technologies Ltd.
  • Exchange sectorTechnology services
  • ISININE306L01010
  • Share price₹153.35 (+12.77% on the day) · 2026-10-14
  • Market capitalisation₹738 Cr
  • EPS (diluted, trailing year)₹-2.05
  • Volume (last session)2,386,634

Financials of Quick Heal

Exchange-reported figures of Quick Heal Technologies Limited, the listed company behind Quick Heal (NSE: QUICKHEAL).

Financial Highlights

FY 2025-26 Β· Consolidated
Revenue
₹261 Cr
-6.6% YoY
EBITDA
−₹29.37 Cr
-345.7% YoY
Profit After Tax
−₹16.76 Cr
-709.5% YoY
Net Worth
₹437 Cr
-1.1% YoY
Total Assets
₹439 Cr
-0.8% YoY
Total Debt
₹0.11 Cr
-64.5% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue261280292278342333286
Revenue growth-6.6%-4.2%+4.9%-18.7%+2.7%+16.4%-
EBITDA(29.37)(6.59)17.551.8810714191.40
EBITDA margin-11.3%-2.4%+6.0%+0.7%+31.3%+42.5%+31.9%
Profit before tax(20.64)1.0026.218.02109146101
Net profit(16.76)2.7522.700.8279.8410572.03
Net profit margin-6.4%+1.0%+7.8%+0.3%+23.4%+31.4%+25.2%
EPS (β‚Ή)(2.02)0.934.531.2114.3416.6611.59
Balance sheet
Total assets439443439421629752646
Net worth437441437420628751644
Total debt0.110.310.000.000.000.000.00
Cash & bank13.2420.9737.7611.8563.0584.3280.03
Net working capital55.2811710875.33158174154
Cash flow
Cash from operations15.39(22.29)18.1930.8179.9898.6270.56
Cash from investing(25.85)15.956.14185126(92.36)148
Cash from financing2.76(10.33)1.60(212)(214)0.10(221)
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue64.9344.9948.7371.5483.5257.2365.1470.61
Revenue growth (YoY)-22.3%-21.4%-25.2%+1.3%+13.7%-18.6%--
Other income8.3414.103.758.954.385.755.604.91
EBITDA2.30(17.57)(29.32)0.459.23(9.73)(8.48)(3.77)
EBITDA margin+3.5%-39.1%-60.2%+0.6%+11.1%-17.0%-13.0%-5.3%
Depreciation5.783.854.073.593.282.963.633.39
Interest0.530.000.030.060.050.060.060.06
Profit before tax4.33(7.32)(29.67)5.7510.28(7.00)(6.57)(2.31)
Tax(1.47)(2.04)(9.73)(0.86)2.37(1.49)(3.32)(2.42)
Net profit5.80(5.28)(19.94)6.617.91(5.51)(3.25)0.11
EPS (β‚Ή)1.03(0.94)(3.56)1.181.42(1.00)(0.60)0.02
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue261280292278342334283
Revenue growth-6.6%-4.2%+4.9%-18.6%+2.4%+17.7%-
EBITDA(28.73)(6.01)17.402.8010214190.76
EBITDA margin-11.0%-2.2%+6.0%+1.0%+29.8%+42.4%+32.0%
Profit before tax(20.14)1.5326.049.29104146100
Net profit(16.26)3.2822.291.8077.8610572.86
Net profit margin-6.2%+1.2%+7.6%+0.7%+22.8%+31.3%+25.7%
EPS (β‚Ή)(1.92)1.034.501.4513.4816.6311.47
Balance sheet
Total assets440443439421629756651
Net worth437442437420627756648
Total debt0.110.310.000.000.000.000.00
Cash & bank12.0717.2336.7110.5659.2077.3973.51
Net working capital55.1911610774.52155166148
Cash flow
Cash from operations17.85(25.00)18.4230.9978.2110070.78
Cash from investing(25.74)15.976.15188130(94.46)146
Cash from financing2.76(10.33)1.60(212)(214)0.11(221)
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue64.9444.9948.7771.5483.5257.2365.1370.54
Revenue growth (YoY)-22.3%-21.4%-25.1%+1.4%+13.5%-18.6%--
Other income8.3314.123.708.864.385.755.544.91
Total expenses62.6362.4078.0170.7574.1366.9072.9874.20
EBITDA2.31(17.41)(29.24)0.799.39(9.67)(7.85)(3.66)
EBITDA margin+3.6%-38.7%-60.0%+1.1%+11.2%-16.9%-12.1%-5.2%
Depreciation5.783.854.073.593.282.963.633.39
Interest0.530.000.030.060.050.060.060.06
Profit before tax4.33(7.14)(29.64)6.0010.44(6.94)(6.00)(2.20)
Tax(1.47)(2.04)(9.73)(0.86)2.37(1.49)(3.32)(2.42)

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 10 Nov 2026
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue64.9344.9948.7371.5483.5257.2365.1470.61
Revenue growth (YoY)-22.3%-21.4%-25.2%+1.3%+13.7%-18.6%--
Other income8.3414.103.758.954.385.755.604.91
EBITDA2.30(17.57)(29.32)0.459.23(9.73)(8.48)(3.77)
EBITDA margin+3.5%-39.1%-60.2%+0.6%+11.1%-17.0%-13.0%-5.3%
Depreciation5.783.854.073.593.282.963.633.39
Interest0.530.000.030.060.050.060.060.06
Profit before tax4.33(7.32)(29.67)5.7510.28(7.00)(6.57)(2.31)
Tax(1.47)(2.04)(9.73)(0.86)2.37(1.49)(3.32)(2.42)
Net profit5.80(5.28)(19.94)6.617.91(5.51)(3.25)0.11
EPS (β‚Ή)1.03(0.94)(3.56)1.181.42(1.00)(0.60)0.02
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue261280292278342333286
Revenue growth-6.6%-4.2%+4.9%-18.7%+2.7%+16.4%-
Other income22.8320.7721.3922.1319.2024.1631.60
Total expenses290286274276235192195
Employee cost183186169155139115101
EBITDA(29.37)(6.59)17.551.8810714191.40
EBITDA margin-11.3%-2.4%+6.0%+0.7%+31.3%+42.5%+31.9%
Depreciation13.9012.9612.6015.9917.3819.4921.68
Interest0.200.220.130.000.000.000.00
Profit before tax(20.64)1.0026.218.02109146101
Tax(9.71)(4.04)1.971.6225.4939.1626.90
Net profit(16.76)2.7522.700.8279.8410572.03
Net profit margin-6.4%+1.0%+7.8%+0.3%+23.4%+31.4%+25.2%
EPS (β‚Ή)(2.02)0.934.531.2114.3416.6611.59
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital54.2454.0053.5153.0758.0164.2164.20
Reserves & surplus382387383367570687580
Shareholders' funds (net worth)437441437420628751644
Minority interest0.000.000.000.000.000.000.00
Secured loans0.000.000.000.000.000.000.00
Unsecured loans0.110.310.000.000.000.000.00
Total debt0.110.310.000.000.000.000.00
Total liabilities439443439421629752646
Assets
Gross block331321308312313316311
Net block122119117124137146158
Capital work in progress0.000.053.060.150.002.113.40
Investments213179190198318416310
Inventories2.592.222.804.504.793.346.24
Sundry debtors138167132123172151113
Cash & bank balances13.2420.9737.7611.8563.0584.3280.03
Loans & advances10.049.199.028.274.759.894.71
Total current assets163199181147245248204
Total current liabilities10882.4873.3071.9486.2074.0250.07
Net working capital55.2811710875.33158174154
Total assets439443439421629752646
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash20.8437.5111.587.8316.4310.0712.96
Net cash from operating activities15.39(22.29)18.1930.8179.9898.6270.56
Net cash from investing activities(25.85)15.956.14185126(92.36)148
Net cash from financing activities2.76(10.33)1.60(212)(214)0.10(221)
Net change in cash(7.70)(16.67)25.933.75(8.60)6.36(2.88)
Closing cash13.2420.9737.7611.8563.0584.3280.03
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth-6.6%-4.2%+4.9%-18.7%+2.7%+16.4%-
EBITDA growth-345.7%-137.6%+833.5%-98.2%-24.5%+54.8%-
PBT growth--96.2%+226.8%-92.6%-25.6%+44.2%-26.1%
Net income growth-709.5%-87.9%+2668.3%-99.0%-23.7%+45.4%-
Revenue CAGR (3Y)-2.1%-6.5%-4.3%-1.0%+2.8%+1.5%-1.6%
EBITDA CAGR (3Y)---50.1%-72.6%-5.8%+5.5%+1.9%
Profitability & leverage
Net income margin-4.2%+1.8%+8.3%+2.3%+24.3%+32.1%+26.0%
Return on capital employed-6.0%-0.2%+6.1%+0.2%+15.7%+20.9%+14.1%
Return on net worth-3.8%+0.6%+5.7%+0.2%+12.1%+15.3%+10.4%
Debt / equity0.000.000.000.000.000.000.00
Long-term debt / equity0.000.000.000.000.000.000.00
Interest cover-0.46-1.132.630.000.000.000.00
Efficiency & per share
Fixed asset turnover0.800.890.940.891.091.060.93
Inventory turnover108.53111.3779.9359.8784.1169.5349.21
Debtors turnover1.721.872.291.892.122.532.40
EPS (β‚Ή)(2.02)0.934.531.2114.3416.6611.59
Dividend per share (β‚Ή)0.000.003.002.504.504.004.00
Book value per share (β‚Ή)80.4881.7681.6779.09108.19117.03100.32
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue64.9444.9948.7771.5483.5257.2365.1370.54
Revenue growth (YoY)-22.3%-21.4%-25.1%+1.4%+13.5%-18.6%--
Other income8.3314.123.708.864.385.755.544.91
Total expenses62.6362.4078.0170.7574.1366.9072.9874.20
EBITDA2.31(17.41)(29.24)0.799.39(9.67)(7.85)(3.66)
EBITDA margin+3.6%-38.7%-60.0%+1.1%+11.2%-16.9%-12.1%-5.2%
Depreciation5.783.854.073.593.282.963.633.39
Interest0.530.000.030.060.050.060.060.06
Profit before tax4.33(7.14)(29.64)6.0010.44(6.94)(6.00)(2.20)
Tax(1.47)(2.04)(9.73)(0.86)2.37(1.49)(3.32)(2.42)
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue261280292278342334283
Revenue growth-6.6%-4.2%+4.9%-18.6%+2.4%+17.7%-
Other income22.6920.7221.3722.4819.1723.9431.34
Total expenses290286274275240192193
Employee cost18218516915513811399.99
EBITDA(28.73)(6.01)17.402.8010214190.76
EBITDA margin-11.0%-2.2%+6.0%+1.0%+29.8%+42.4%+32.0%
Depreciation13.9012.9612.6015.9917.3819.4821.66
Interest0.200.220.130.000.000.000.00
Profit before tax(20.14)1.5326.049.29104146100
Tax(9.71)(4.04)1.971.5925.3739.0426.81
Net profit(16.26)3.2822.291.8077.8610572.86
Net profit margin-6.2%+1.2%+7.6%+0.7%+22.8%+31.3%+25.7%
EPS (β‚Ή)(1.92)1.034.501.4513.4816.6311.47
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital54.2454.0053.5153.0758.0164.2164.20
Reserves & surplus383388383367569692584
Shareholders' funds (net worth)437442437420627756648
Secured loans0.000.000.000.000.000.000.00
Unsecured loans0.110.310.000.000.000.000.00
Total debt0.110.310.000.000.000.000.00
Total liabilities440443439421629756651
Assets
Gross block330321308312313316311
Net block122119117124137146158
Capital work in progress0.000.053.060.150.002.113.40
Investments214180191198321428320
Inventories2.592.222.804.504.793.296.22
Sundry debtors140170132123173149113
Cash & bank balances12.0717.2336.7110.5659.2077.3973.51
Loans & advances9.969.128.918.214.689.734.58
Total current assets165199180146242240198
Total current liabilities10982.7573.3871.5286.6373.5649.35
Net working capital55.1911610774.52155166148
Total assets440443439421629756651
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash17.1036.4610.293.979.503.567.96
Net cash from operating activities17.85(25.00)18.4230.9978.2110070.78
Net cash from investing activities(25.74)15.976.15188130(94.46)146
Net cash from financing activities2.76(10.33)1.60(212)(214)0.11(221)
Net change in cash(5.13)(19.36)26.176.32(5.53)5.94(4.41)
Closing cash12.0717.2336.7110.5659.2077.3973.51
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth-6.6%-4.2%+4.9%-18.6%+2.4%+17.7%-
EBITDA growth-378.0%-134.5%+521.4%-97.3%-28.0%+55.8%-
PBT growth--94.1%+180.3%-91.0%-29.0%+45.2%-22.2%
Net income growth-595.7%-85.3%+1138.3%-97.7%-25.5%+43.4%-
Revenue CAGR (3Y)-2.1%-6.5%-4.4%-0.6%+3.0%+1.8%-1.8%
EBITDA CAGR (3Y)---50.3%-68.6%-5.4%+6.8%-0.8%
Profitability & leverage
Net income margin-4.0%+2.0%+8.3%+2.8%+22.9%+32.0%+26.0%
Return on capital employed-5.8%-0.1%+6.1%+0.4%+15.0%+20.7%+13.9%
Return on net worth-3.7%+0.8%+5.6%+0.3%+11.3%+15.2%+10.2%
Debt / equity0.000.000.000.000.000.000.00
Long-term debt / equity0.000.000.000.000.000.000.00
Interest cover-0.47-1.162.710.000.000.000.00
Efficiency & per share
Fixed asset turnover0.800.890.940.891.091.060.92
Inventory turnover108.55111.3779.9359.8784.5470.1454.71
Debtors turnover1.681.852.291.882.122.542.38
EPS (β‚Ή)(1.92)1.034.501.4513.4816.6311.47
Dividend per share (β‚Ή)0.000.003.002.504.504.004.00
Book value per share (β‚Ή)80.6181.8281.6579.09108.12117.71100.96

Investments & Acquisitions by Quick Heal

Quick Heal has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Junco Technologies.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
IT security consulting and services are offered to enterprises.
juncotech.comPune, India2014Jun 2016β€’β€’β€’β€’
Premium access

Complete acquisition details for Quick Heal

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Quick Heal

5 dated milestones of Quick Heal across 21 years, from founding to its latest funding, stage changes and deals.

  1. Founded Quick Heal is founded.
  2. Funding First funding round of $8.3M.
  3. Milestone Reaches Minicorn status.
  4. IPO Lists on the stock exchange (IPO).
  5. Acquisition Acquires Junco Technologies.

Web traffic of Quick Heal

The website of Quick Heal (quickheal.co.in) receives about 501.6K visits a month and ranks #107,677 among all websites worldwide, #832 in Search Engines.

  • Monthly visits
    501.6K

    ▲ 4% vs previous month

  • Unique visitors
    276.1K

    per month

  • Global rank
    #107,677

    among all websites

  • Category rank
    #832

    Computers Electronics and Technology · Search Engines

Similar websites

Websites whose visitors overlap most with Quick Heal. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
kaspersky.co.in
100%
309.6K#153,567View details
avast.com
74%
12.7M#4,813View details
justdial.com
67%
91.3M#480View details
music.youtube.com
music.youtube.com
62%
#72–
eset.com
62%
6M#6,641View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 40 similar websites and full traffic analytics for Quick Heal

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 40 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Quick Heal

Premium access

Complete news archive for Quick Heal

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Quick Heal

Quick Heal was founded in 1995 and raised its 1st funding round 15 years after it was founded.

Quick Heal is headquartered in Pune, India. It is registered at Pune, Maharashtra, India.

Kailash Katkar is the CEO of Quick Heal, as recorded in our data. They have also founded this company.

Quick Heal has 977 employees.

The primary company behind Quick Heal, Quick Heal Technologies Limited, reported revenue of β‚Ή284 Cr for FY 2026, down 7% year on year.

Quick Heal was founded in 1995 in Pune, India, within the cybersecurity sector. A cloud-based platform is operated to provide endpoint security through antivirus solutions for PCs, laptops, Macs, and Windows devices. Protection from cyber attacks and threats is ensured, supporting device performance and user security across operations.

Yes, Quick Heal is publicly traded on NSE under the ticker symbol QUICKHEAL.

Quick Heal has made 1 acquisition, including Junco Technologies.

Quick Heal has 2 investors. Key investors include Peak XV Partners, and RippleWave.

The valuation of Quick Heal is $124.91M as of Aug 2010.

Quick Heal is associated with 2 legal entities: Quick Heal Technologies Limited, Gagan Bharari Enterprises Llp.

The legal entities of Quick Heal currently have 10 directors, including Pooja Parag Rathi, Amod Santosh Tirmanwar, Kailash Sahebrao Katkar and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available